Novel cell penetrating peptides with multiple motifs composed of RGD and its analogs

Biochemical and Biophysical Research Communications

Volumn 432, Issue 2, 2013, Pages 359-364

  Mokhtarieh, Amir Abbas ^a,b   Kim, Semi ^a,b   Lee, Yunhee ^a   Chung, Bong Hyun ^a,b   Lee, Myung Kyu ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

Author keywords

Cell penetrating peptide (CPP); CPP mediated liposome uptake; Gene silencing; Peptide cytotoxicity; RGD motif

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CELL PENETRATING PEPTIDE; SMALL INTERFERING RNA;

ARTICLE; CELL ENCAPSULATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; GENE ACTIVITY; GENE EXPRESSION; GENE SILENCING; INTERNALIZATION; PRIORITY JOURNAL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ASPARTIC ACID; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; GENE SILENCING; GLUTAMIC ACID; HUMANS; LIPOSOMES; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; OLIGOPEPTIDES; RNA, SMALL INTERFERING;

ANIMALIA;

EID: 84875249441     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.096     Document Type: Article

References (25)

1. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 1994, 269:10444-10450.
2. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
3. Pooga M., Hallbrink M., Zorko M., Langel U. Cell penetration by transportan. FASEB J. 1998, 12:67-77.
4. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997, 88:223-233.
5. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 1995, 270:14255-14258.
6. Milletti F. Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov. Today 2012, 17:850-860.
7. Sanders W.S., Johnston C.I., Bridges S.M., Burgess S.C., Willeford K.O. Prediction of cell penetrating peptides by support vector machines. PLoS Comput. Biol. 2011, 7:e1002101.
8. Hansen M., Kilk K., Langel U. Predicting cell-penetrating peptides. Adv. Drug Deliv. Rev. 2008, 60:572-579.
9. Scheller A., Oehlke J., Wiesner B., Dathe M., Krause E., Beyermann M., Melzig M., Bienert M. Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J. Pept. Sci. 1999, 5:185-194.
10. Oehlke J., Krause E., Wiesner B., Beyermann M., Bienert M. Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide. FEBS Lett. 1997, 415:196-199.
11. Taylor B.N., Mehta R.R., Yamada T., Lekmine F., Christov K., Chakrabarty A.M., Green A., Bratescu L., Shilkaitis A., Beattie C.W., Das Gupta T.K. Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res. 2009, 69:537-546.
12. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
13. Mokhtarieh A.A., Cheong S., Kim S., Chung B.H., Lee M.K. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery. Biochim. Biophys. Acta 1818, 2012:1633-1641.
14. Jung H., Lee K.P., Park S.J., Park J.H., Jang Y.S., Choi S.Y., Jung J.G., Jo K., Park D.Y., Yoon J.H., Lim D.S., Hong G.R., Choi C., Park Y.K., Lee J.W., Hong H.J., Kim S., Park Y.W. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 2008, 27:2635-2647.
15. Baker M.A., Maloy W.L., Zasloff M., Jacob L.S. Anticancer efficacy of magainin2 and analogue peptides. Cancer Res. 1993, 53:3052-3057.
16. Tossi A., Sandri L., Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 2000, 55:4-30.
17. Bayless K.J., Salazar R., Davis G.E. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am. J. Pathol. 2000, 156:1673-1683.
18. Mok H., Lee S.H., Park J.W., Park T.G. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat. Mater. 2010, 9:272-278.
19. Erbacher P., Remy J.S., Behr J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 1999, 6:138-145.
20. Gupta A.S., Huang G., Lestini B.J., Sagnella S., Kottke-Marchant K., Marchant R.E. RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system. Thromb. Haemost. 2005, 93:106-114.
21. Larzabal L., Nguewa P.A., Pio R., Blanco D., Sanchez B., Rodriguez M.J., Pajares M.J., Catena R., Montuenga L.M., Calvo A. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br. J. Cancer 2011, 105:1608-1614.
22. Fuchs S.M., Raines R.T. Pathway for polyarginine entry into mammalian cells. Biochemistry 2004, 43:2438-2444.
23. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J. Biol. Chem. 2005, 280:15300-15306.
24. Saar K., Lindgren M., Hansen M., Eiriksdottir E., Jiang Y., Rosenthal-Aizman K., Sassian M., Langel U. Cell-penetrating peptides: a comparative membrane toxicity study. Anal. Biochem. 2005, 345:55-65.
25. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., Lindsay M.A. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 2005, 145:1093-1102.